S100A8 and gastric cancer: In terms of immunological perspective, CagA increases the expression of programmed death ligand-1 (PD-L1) in gastric cancer-cell-derived exosomes by inhibiting p53 and miRNA-34a, which inhibits proliferation and anticancer effects induced by CD8+T cells (18).